Medrx Co

Medrx Co Current Liabilities

Current Liabilities of Medrx Co (4586.T) as of Nov 19, 2026.

Current Liabilities

-JPY

Last updated:

Current Liabilities of Medrx Co is 2026 - JPY. Current Liabilities of Medrx Co was 2025 - JPY. It decreases by % lower compared to the previous year.

The Medrx Co Current Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Liabilities
Date
Current Liabilities
Jan 1, 2007
46.40 M JPY
Jan 1, 2008
46.60 M JPY
Jan 1, 2010
66.05 M JPY
Jan 1, 2011
109.67 M JPY
Jan 1, 2014
65.53 M JPY
Jan 1, 2015
98.10 M JPY
The Medrx Co Current Liabilities history
YEARCurrent LiabilitiesYoY
98.10 MJPY+49.71%
65.53 MJPY-40.25%
109.67 MJPY+66.04%
66.05 MJPY+41.74%
46.60 MJPY+0.43%
46.40 MJPY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Medrx Co Stock analysis

What does Medrx Co do? Medrx Co. Ltd. develops pharmaceutical drugs using transdermal absorption technology, focusing on percutaneous absorption through ionic liquid transdermal system (ILTS) and nano-sized colloid transdermal system (NCTS). The company aims to maximize drug efficacy, reduce side effects, and provide alternatives for patients who cannot take oral medications. Its products target new markets by offering medicines with enhanced delivery systems and added value. The firm's technology includes ionic liquid transdermal system (ILTS) leveraging ionic liquid characteristics and nano-sized colloid transdermal system (NCTS) utilizing nano colloidization technology. These systems enable precise drug delivery, addressing challenges in oral administration and improving patient compliance. The company's products are designed to serve patients requiring non-oral medication options. Medrx Co. Ltd. produces medicines based on percutaneous absorption formulation technology, targeting healthcare providers and patients who need alternative drug administration methods. The company's focus on transdermal systems allows it to address specific medical needs, such as preventing forgotten doses and reducing side effects associated with traditional oral drugs. Medrx Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Medrx Co stock

On Eulerpool you can find the complete historical development of Current Liabilities Medrx Co since 2006 – with annual values, charts, and detailed analysis.

Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.

Current Liabilities's JPY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's Medrx Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Medrx Co

All Key Metrics — Medrx Co